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Abstract A retrospective analysis of108 patients admitted to the hospital for hemoptysis in the year 2000 was per-
formed.The aim of the study was to clarify the etiologic distribution of hemoptysis and the relation of etiology to the
severity and recurrence of it.Of the cases,79 weremen and 29 werewomen, and themean age was 51.74717.51. In 77
ofthecasesitwas the ¢rst attack,whilein 31itwasrecurrent.According tothe severityof hemoptysis, itwasclassi¢edas
‘‘mild’’ (o30 cm3),‘‘moderate’’ (30^100 cm3),‘‘severe’’ (100^600 cm3) and‘‘massive’’ (4600 cm3).Lungcancerwas thelead-
ing cause of hemoptysis (34.3%) followed by bronchiectasis (25.0%), tuberculosis (17.6%), pneumonia (10.2%) and pul-
monary embolism (4.6%). Statistical analysis by chi-square test revealed that most of the lung cancer patients had mild
hemoptysis (odds ratio 3.5; Po0.05), and themost frequent etiology in recurrent hemoptysis was bronchiectasis (odds
ratio 3.25; P=0.01).Most of the lung cancer patients were male (P=0.002).The two leading causes of hemoptysis in our
study are similar to many previous reports.The high rate of tuberculosis in our study is probably due to the high preva-
lence of tuberculosis in ourcountry.r2002 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2002.1359, available online athttp://www.idealibrary.comon
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Hemoptysis is generally accepted as an alarming symp-
tom. Its etiology varies among di¡erent series according
to the geographic location, the time of publication and
the diagnostic tests employed. Much of the knowledge
about the etiologic factors of hemoptysis depends on
the data collected between1930 and1960 (1^5). In those
studies, bronchiectasis, tuberculosis or bronchogenic
carcinoma are the leading causes but the relation be-
tween the cause of hemoptysis and its severity is notwell
de¢ned. E⁄cient tuberculosis control program in devel-
oped countries are themain reason for the di¡erences in
etiologic distribution. Also improvement in the diagnos-
tic feasibilities and thewidespreaduse of antibiotics have
changed the prevalence of diseases causing hemoptysis
(1,6^9).
Chest X-ray, thorax computed tomography (CT) and
¢beroptic bronchoscopic examination (FOB) are the
most frequently used diagnostic technics but there is no
consensus about the procedure of choice in certain con-
ditions (7^15).
The aimof this study is to clarify the etiologic distribu-
tion of hemoptysis in our clinic and to determine the re-
lation of etiology to the severity and recurrence of it.Correspondence should be addressed to: Sevda zdog! an,MD,MSc,
Tˇccar Katibi sok. 50.Yil apt. 8/16, 81070 Suadiye, Istanbul,Turkey.
Fax: +90 216 4632833; E-mail: sozdogan@superonline.comMETHODS
A total of 108 patients with hemoptysis admitted to
Dr Lˇt¢ Kirdar Kartal Education and Research Hospital,
Department of Chest Diseases in the year 2000 were
included in the study.Of the cases, 83 were hospitalized
whereas 25 were examined on an outpatient basis.
According to the amount of daily bleeding (severity
of hemoptysis), the patients were divided into four
groups: ‘‘mild’’: only streaking of sputum or less than
two tablespoons (o30cm3); ‘‘moderate’’: 30^100 cm3;
‘‘severe’’: 100^600 cm3; ‘‘massive’’:4600 cm3. Apart
from the ‘‘¢rst attack’’ of hemoptysis, repeated attacks
with a minimum of 30 days interval were accepted
as ‘‘recurrent hemoptysis.’’ The records of the patients
were examined for age and sex distribution, medical
history, severity and recurrence of hemoptysis, diagnos-
tic procedures and de¢nite diagnosis. Chest X-ray
in all the cases, FOB in 52, thorax CT/HRCT in 79,
sputum smear for acid-fast bacilli (AFB) in 34 and
some other procedures like echocardiography, ventila-
tion^perfusion scintigraphy, etc. were performed in 12
cases.
In data analysis, chi-square test and odds ratio risk
estimate calculations of the Statistical Package for
Social Sciences (SPSS) program were used. Po0.05
was accepted as statistically signi¢cant and the
odds ratio was calculated in a 95% con¢dence
interval.
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Among the total of 108 cases, 79 (73.1%) were male and
29 (26.9%) were female with a mean age of 51.74717.51.
The diagnostic distribution of the patients is presented
in Fig. 1. Sixty-¢ve were smokers (mean smoking dura-
tion: 35.92 pack-years), 12 had a history of tuberculosis,TABLE 3: Diagnostic distribution according to the severityand
Diagnosis N (%)
First Recurrent
Lungcancer 30 (38.9) 7 (22.6)
Bronchiectasis 14 (18.2) 13 (41.9)
Tuberculosis 16 (20.8) 3 (9.7)
Pneumonia 7 (9.1) 4 (12.9)
P. embolism 5 (6.5) F
Othera 5 (6.5) 4 (12.9)
Toplam 77 (100) 31 (100)
aOther:COPD (two cases), hydatid cyst (two cases), sarcoido
case each) a casewithmassive hemoptysiswho obtained the dia
TABLE 1: Thorax CTresults of the patients
Result N %
Normal 2 2.5
Mass lesion 34 43.1
Bronchiectasis 29 36.7
Athelectasis 5 6.3
In¢ltration 5 6.3
Cavity 2 2.5
Cyst 1 1.3
Fibrosis 1 1.3
Total 79 100
%1.9
%1.9% 4.6
% 4.6
% 2
%17.6
%10.2
*: Sarcoidosis, amiloidosis, mytral i
vascular lesion 
Fig. 1. Diagnostic distribution of patients.32 patients had concomitant disease like hypertension
(¢ve cases), asthma (four cases) and malignancy (four
cases).
In chest X-ray examination eight patients had normal
chest X-ray. Among these patients, bronchiectasis (¢ve
cases), tuberculosis, mitral insu⁄ciency and vascular ab-
normality were detected with further examinations.recurrence of hemoptysis
N (%)
Mild Moderate Severe
30 (44.1) 5 (26.3) 2 (10.0)
12 (17.6) 7 (36.8) 8 (40.0)
9 (13.2) 3 (15.8) 7 (35.0)
9 (13.2) 1 (5.3) 1 (5.0)
4 (5.9) F 1 (5.0)
4 (5.9) 3 (15.8) 1 (5.0)
68 (100) 19 (100) 20 (100)
sis, amyloidosis,Mitralinsu⁄ciency, iatrogenic hemoptysis (one
gnosis of vascular pathology is not included inthe table).
TABLE 2. FOBresults of the patients
Result N %
Normal 7 13.5
Endobronchial lesion 31 59.6
Edema, hyperemia (infection) 6 11.6
Extrinsic compression 5 9.6
Circumferentialnarrowing 2 3.8
Organizingcoagulum 1 1.9
Total 52 100
% 34.2
5.0
lung cancer
bronchiectasis
tuberculosis
pneumonia
p.embolism
hydatid cyst
COPD
other*
nsufficiency, iatrogenic hemoptysis,
T
A
B
LE
4.
H
em
op
ty
sis
et
io
lo
gy
in
di
¡e
re
nt
se
ri
es
Se
ri
es
Sa
ud
er
sa
nd
Sm
ith
(3
)
M
oe
rs
ch
(2
)
Sa
nt
ia
go
et
al
.(
6)
Jo
hn
st
on
an
d
R
ei
sz
(1)
M
cG
ui
nn
es
et
al
.(
7)
H
ir
sb
er
g
et
al
.(
8)
CF
el
ik
et
al
.(
9)
A
ba
le
ta
l.
(1
6)
C
ur
re
nt
se
ri
es
C
om
bi
na
tio
n
of
th
e
se
ri
es
(m
ea
n
va
lu
es
)
Ye
ar
19
41
^5
1
19
50
19
74
^8
1
19
77
^8
5
19
91
^9
2
19
80
^9
5
19
95
^9
6
19
98
^9
9
20
00
Lo
ca
tio
n
La
he
y
C
lin
ic
,
B
os
to
n
M
ay
o
C
lin
ic
Lo
s
A
ng
el
es
K
an
sa
s
C
it
y
N
ew
Yo
rk
Je
ru
sa
le
m
,
Isr
ae
l
Is
ta
nb
ul
,
Tu
rk
ey
Ku
w
ai
t
Is
ta
nb
ul
,
Tu
rk
ey
N
o.
of
ca
se
s
10
5
20
0
26
4
14
8
57
20
8
15
5
52
10
8
12
97
Br
on
ch
ie
ct
as
is
(%
)
28
.5
26
.5
0.
5
1
25
20
9
21
.2
25
17
.4
Lu
ng
ca
nc
er
(%
)
3
29
.5
29
19
12
19
48
F
34
.3
42
.3
Br
on
ch
iti
s
(%
)
12
.4
9
23
37
5
18
F
5.
8
F
15
.7
Pn
eu
m
on
ia
(%
)
1
8
11
5
12
16
13
F
10
.2
9.5
Tu
be
rc
ul
os
is
(%
)
1.9
5.
5
6
7
16
1
12
15
.4
17
.6
9.2
N
o
di
ag
no
sis
(%
)
18
F
22
3
19
8
1
25
F
13
.7
O
th
er
(%
)
35
21
.5
9
28
5
18
17
1.9
12
.9
16
.5
HEMOPTYSIS 679Fifty-¢ve patients (50.9%) had localized and 45 patients
(41.7%) had nonlocalized lesion on chest X-ray.Themost
frequent pathology on thorax CTwas the mass lesion
(43.1%) followed by bronchiectasis (36.7%) (Table1). Spu-
tum smear for AFB was positive in 10 out of 34 patients
examined. Among the remaining 24 sputum AFB-nega-
tive cases, six had a diagnosis of tuberculosis with re-
spect to clinical and radiological consideration. Also,
three cases who could not give sputum for examination
had a diagnosis of tuberculosis with similar criteria. FOB
was performed in 52 (48.1%) cases with the most fre-
quent ¢nding of endobronchial lesion (Table 2).
The diagnostic distribution according to the charac-
teristics of hemoptysis is seen inTable 3. Eighty-one per-
cent of the patients with lung cancer had mild
hemoptysis while it was 53.5% in the noncancer group.
The odds ratio for lung cancer in mild hemoptysis was
calculated as 3.5 (1.360^9.034 in 95% con¢dence interval)
(Po0.05). The most frequent diagnosis in recurrent he-
moptysis was bronchiectasis (41.9%) and the odds ratio
for bronchiectasis in recurrent hemoptysis was 3.25
(1.297^8.146 in 95% con¢dence interval) (P=0.01).
Although the most frequent diagnosis was lung cancer
in the ¢rst attack of hemoptysis, it was not statistically
signi¢cant.Malepredominance existed in the lung cancer
group (P=0.002).
DISCUSSION
Lung cancer, bronchiectasis, bronchitis, pneumonia and
tuberculosis are themain causes of hemoptysis reported
in di¡erent series, but the frequencies vary according to
the characteristics of the patient population, geographic
location and the time of publication (Table 4) (1^9).When
we consider the previous series about the subject, in
general, lung cancer is the leading cause of hemoptysis
(42.3%). It is followedby bronchiectasis (17.4%) and bron-
chitis (15.7%). In our series, lung cancer was the leading
cause (34.3%) followed by bronchiectasis (25%) and tu-
berculosis (17.6%).The rate of bronchiectasis is very low
in the series of Santiago et al. (6) and Johnston and Reisz
(1) but itmight have been underdiagnosed as, in these in-
vestigations bronchography was rarely used while CT/
HRCTwas not used.Recent reports have demonstrated
a higher sensitivityof CT compared to bronchoscopic ex-
amination in detecting bronchiectasis (7).The rate of tu-
berculosis in our series is high compared to some other
reports (1,2,6)which canbe due to thehighprevalence of
tuberculosis in our country. Also, there are some other
reports from our country with similar rates of tubercu-
losis (9).Yavas,ogﬂ lu et al. from Istanbul,Turkey, have found
a higher rate of tuberculosis (56%) among patients with
hemoptysis compared to our series, but as they have
performed their research in a reference hospital of
tuberculosis, their results may be based on a selected
680 RESPIRATORYMEDICINEpopulation (17). In the series of McGuinness et al. (7) and
Abal et al. (16), the rate of tuberculosis is similar to our
result.These authorsmention thereemergence of tuber-
culosis in their country, which they say can also be the
reason for the rising incidence of bronchiectasis.
There was a signi¢cant high rate of mild hemoptysis
among lung cancer patients in our series. Although some
authors insist on the fact that the severity of hemoptysis
is not a goodpredictor of the underlying disease (1,15,18),
there are also some reports that have found a signi¢cant
relation between the rate of lung cancer diagnosis and
themild characteristic of hemoptysis (7,9,17). Irreversible
bronchial deformation in bronchiectasis patients usually
causes persisting intermittent hemoptysis. Consistent
with thiswe found a signi¢canthigh rate of recurrent he-
moptysis in our patients with bronchiectasis.
We conclude that lung cancer and bronchiectasis are
the most frequent causes of hemoptysis in our series.
The high rate of tuberculosis, being the third leading
cause, can be due to the high prevalence of tuberculosis
in our country. In a patient with mild hemoptysis and
male sex, lung cancer should be themost probable diag-
nosis whereas in a history of recurrent hemoptysis,
bronchiectasis should be considered ¢rst.
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